Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.54 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.54 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.54 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28225640 | 0.87 | MAPT (0.71) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL3453977 | 0.87 | MAPT (0.71) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL574913 | 0.86 | PRKCA (0.69) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL28756217 | 0.83 | MAPT (0.68) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL7109203 | 0.83 | MAPT (0.68) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL29356774 | 0.83 | KDM4E (0.63) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL2703002 | 0.82 | PRKCA (0.72) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL5155403 | 0.82 | PRKCA (0.72) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL20202521 | 0.82 | MAPT (0.68) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL29363445 | 0.82 | LMNA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220008319-A1 | HAIR COSMETIC AND HAIR TREATMENT METHOD USING SAME | SHISEIDO COMPANY, LTD. (JP) | 2022-01-13 | — | — | US | disclosed |
| EP-3875153-A1 | HAIR COSMETIC AND HAIR TREATMENT METHOD USING SAME | Shiseido Company, Ltd. (JP) | 2021-09-08 | — | — | EP | disclosed |
| US-9839588-B2 | Skin external preparation comprising an aqueous dispersion of finely dispersed wax, nonionic surfactant, and ionic water-soluble thickener | SHISEIDO COMPANY, LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-20120189675-A1 | Skin External Preparations | SHISEIDO COMPANY, LTD. (JP) | 2012-07-26 | — | — | US | disclosed |
| EP-2415459-A1 | EXTERNAL PREPARATION FOR SKIN | Shiseido Company, Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100316581-A1 | Skin External Preparations | SHISEIDO COMPANY, LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| EP-2233154-A1 | SKIN EXTERNAL PREPARATION | Shiseido Company, Ltd. (JP) | 2010-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120189675-A1 | Skin External Preparations | CUTA, KRT18, CD69 | PRKCA 1998/4885PRKCE 837/4885PRKCQ 1216/4885 |
| US-20220008319-A1 | HAIR COSMETIC AND HAIR TREATMENT METHOD USING SAME | SGMS1, POLR1C, SGMS2 | PRKCA 3608/4885PRKCE 3460/4885PRKCQ 3883/4885 |
| US-20100316581-A1 | Skin External Preparations | CUTA, RBP4, TTPA | PRKCA 2828/4885PRKCE 2891/4885PRKCQ 2957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.